These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19656511)

  • 1. The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis.
    Ardigò D; Franzini L; Valtueña S; Numeroso F; Piatti PM; Monti L; Reaven GM; Zavaroni I
    Atherosclerosis; 2010 Jan; 208(1):240-5. PubMed ID: 19656511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
    Targher G; Bertolini L; Scala L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Oct; 22(10):1354-8. PubMed ID: 16176196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
    Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
    Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
    de Larrañaga G; Wingeyer SP; Graffigna M; Belli S; Bendezú K; Alvarez S; Levalle O; Fainboim H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):319-24. PubMed ID: 18160600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
    Ardigò D; Numeroso F; Valtueña S; Franzini L; Piatti PM; Monti L; Delsignore R; Reaven GM; Zavaroni I
    Metabolism; 2005 Dec; 54(12):1566-70. PubMed ID: 16311087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
    Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
    Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
    Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between changes in plasma leptin concentrations and plasminogen activator inhibitor-1 in obese prepubertal children after nine months of treatment.
    Valle Jiménez M; Martos R; Morales RM; Valle R; Cañete MD; Urbano MM; Bermudo F; Cañete R
    Ann Nutr Metab; 2013; 63(3):216-22. PubMed ID: 24135306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight.
    Holzberg JR; Jin R; Le NA; Ziegler TR; Brunt EM; McClain CJ; Konomi JV; Arteel GE; Vos MB
    J Pediatr Gastroenterol Nutr; 2016 Jun; 62(6):819-23. PubMed ID: 26704864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy.
    Stejskal D; Růzicka V; Fanfrdlová G; Kolár V; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):93-9. PubMed ID: 16170395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study.
    Raiko JR; Oikonen M; Wendelin-Saarenhovi M; Siitonen N; Kähönen M; Lehtimäki T; Viikari J; Jula A; Loo BM; Huupponen R; Saarikoski L; Juonala M; Raitakari OT
    Atherosclerosis; 2012 Sep; 224(1):208-12. PubMed ID: 22840426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturated fatty acid intake can influence increase in plasminogen activator inhibitor-1 in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Corgosinho FC; Carnier J; Oyama LM; do Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Horm Metab Res; 2014 Apr; 46(4):245-51. PubMed ID: 24619821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
    Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
    Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion.
    Huang W; Dedousis N; O'Doherty RM
    J Appl Physiol (1985); 2007 Jun; 102(6):2260-5. PubMed ID: 17363621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.